New research published in the journal BMC Complementary and Alternative Medicine shows Modified Citrus Pectin (MCP) packs a powerful immune punch. The study uses human blood samples to demonstrate the ability of a specific form of Modified Citrus Pectin to very significantly induce and enhance the benefits of T-cytotoxic cells and human Natural Killer (NK) cells. The NK-cell’s cancer killing activity was demonstrated in live leukemia cancer cells, uncovering yet another mechanism of MCP’s powerful anti-cancer actions. Immune researchers at the Dharma Biomedical LLC (Miami, FL) and the Department of Pathology at Miami Children’s Hospital are excited: “The Modified Citrus Pectin we researched has potential for altering the course of certain viral diseases such as the common cold or other upper respiratory tract viral infections based on the mechanisms of action that were observed in this study,” says lead researcher Steve Melnick.
Read more at: http://www.marketwatch.com/story/modified-citrus-pectin-packs-powerful-immune-punch-2011-09-01
